Navigation Links
Johns Hopkins receives funding for cholera vaccine initiative
Date:12/27/2012

The Johns Hopkins Bloomberg School of Public Health was awarded a four-year, $5 million grant from the Bill & Melinda Gates Foundation to promote the effective use of oral cholera vaccine around the world. The Delivering Oral Vaccine Effectively (DOVE) program will provide relief agencies and governments with technical assistance on how to use oral cholera vaccine, evaluate current vaccine-use practices and develop new field surveillance methods for monitoring and controlling outbreaks of the disease.

Cholera is an infectious disease caused by drinking unsanitary water. The disease is estimated to be responsible for between 100,000 to 200,000 deaths worldwide each year and infects as many as 2.5 million people annually. The oral cholera vaccine is over 70 percent effective and costs $1.85 per dose, but is not yet widely used in preventing outbreaks.

"We believe this grant will greatly facilitate the appropriate use of the new cholera vaccine. In partnership with the World Health Organization, UNICEF and other national and international agencies, we believe the DOVE project will provide the knowledge, technical assistance and encouragement to bring this life-saving vaccine to those who need it most," said David Sack, MD, director of DOVE and professor in the Department of International Health at the Bloomberg School.

In addition to researching and evaluating vaccine-use practices, DOVE will establish cholera surveillance in the northern region of Cameroon near Lake Chad, which appears to be a cholera hotspot. The site will help researchers develop and study methods for detecting outbreaks in remote areas and potentially for using oral vaccine to contain the disease.

The DOVE program will be part of a network of vaccine projects funded by the Gates Foundation to prevent outbreaks of cholera worldwide.


'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
2. A Serious Problem: Medical Malpractice Lawyers at Console & Hollawell React to Alarming Doctor Error Statistics from Johns Hopkins University Researchers
3. US Drug Watchdog Now Fears Most Women Never Heard About Yaz or Yasmin Birth Control Pill Side Effects and They Urge to Victims to Call the Johnson Law Group-Get Help Now
4. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
5. Johns Hopkins malpractice study: Surgical never events occur at least 4,000 times per year
6. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. Johns Hopkins to aid The Leapfrog Group in grading the safety and quality of US hospitals
9. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or a Heart Attack to Call the Johnson Law Group Now-Before Time Runs Out
11. Fasting may benefit patients with epilepsy, Johns Hopkins Childrens Center study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Americans live closer to their dogs ... Veterinary Medical Association (AVMA) U.S. Pet Ownership and Demographics ... their dog a member of the family, up from ... five years earlier. , According to the American Pet ... income dedicated to pets has increased every year without ...
(Date:5/19/2013)... 2013 The Fat Loss Code program developed ... that help people get in shape, and gain a ... The program also is a natural fat loss system that ... author of this fat loss diet program claimed that The ... help people keep body fat off long-term. After Shawn Stevenson ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Agora Health Limited ... that covers guides on how to increase memory power ... memory training method that helps people re-new their entire health ... and beat depression caused by a fatigued mind. In addition, ... razor sharp for a lifetime. The author claimed that this ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Beginning Wednesday, May ... Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" and ... RRVBC will provide hot dogs and all the fixin's ... slushies each day throughout the summer. “Donors are our lifeline. ... a stable and adequate blood supply. This is a ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
Breaking Medicine News(10 mins):Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... Japan, March 30 ... reorganization of its corporate structure, as part of ... global pharmaceutical company with highly integrated global operations. ... changes in the global operating environment and to ...
... The American Association of Oral and Maxillofacial ... Oral Health Rehabilitative Enhancement Act of 2009" (H.R. 1430 IH), ... referring their Medicare patients for physical therapy. Introduced on March ... (D-N.J.) and Congressman Eric Cantor (R-Va.), ...
... MOUNT PROSPECT, Ill., March 30 Introduced by ... in February 1999, the Verified Internet Pharmacy Practice ... patients. The VIPPS program enables consumers to confidently ... of legitimate Internet pharmacies in the nation. A ...
... March 30 VisionCare Ophthalmic Technologies, Inc., a ... with age-related macular degeneration (AMD), today announced the ... the FDA approve, with conditions, the premarket application ... The implantable telescope is the first medical device ...
... technique to distinguish benign moles from malignant melanomas ... Standard microscopic examinations of biopsied tissue can ... and supplementing standard practice with the new technique ... In a large study of previously diagnosed cases, ...
... A new study shows that people with multiple sclerosis may ... a higher risk of developing certain types of cancer, such ... in the March 31, 2009, print issue of Neurology ... , Researchers looked at the medical records of ...
Cached Medicine News:Health News:Takeda to Create Global Centers of Excellence 2Health News:Takeda to Create Global Centers of Excellence 3Health News:Takeda to Create Global Centers of Excellence 4Health News:AAOMS Applauds Legislation Enabling Medicare Patients to Rehabilitate and Recover More Efficiently From Oral and Maxillofacial Injuries 2Health News:VIPPS Celebrates 10th Anniversary, Continues to Guide Consumers to Legitimate Internet Pharmacies 2Health News:VIPPS Celebrates 10th Anniversary, Continues to Guide Consumers to Legitimate Internet Pharmacies 3Health News:FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration 2Health News:FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration 3Health News:New strategy developed to diagnose melanoma 2Health News:New strategy developed to diagnose melanoma 3Health News:Multiple sclerosis associated with lower cancer risk 2
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... 2013  Today, the National Patient Advocate Foundation acknowledges ... of Representatives recently approved a bill that would prohibit ... higher out-of-pocket fees for newer, more expensive oral anti-cancer ... more severe side-effects. However, the bill was amended to ... continue to be a barrier to patients with cancer ...
(Date:5/16/2013)... , May 16, 2013  Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... 2011 Healthpoint today announced the launch of a ... Biotherapeutics, along with an updated brandmark and corporate tagline, ... is designed to communicate the company,s commitment to scientific ... contribute to improved outcomes and quality of life for ...
... Md., Feb. 23, 2011 The Cystic Fibrosis Foundation and ... development that targets the defective protein that causes cystic fibrosis, ... The trial was designed to evaluate patients age ... a CF mutation called G551D. The study included 161 patients ...
Cached Medicine Technology:Healthpoint Launches New Corporate Identity 2Healthpoint Launches New Corporate Identity 3Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
... CCR Medical's Articulating Tip ... units in the Industry. The ... intubation by providing an improved ... Conventional and Fiber Optic styles. ...
German Style MacIntosh Fiber Optic Blade Laryngoscopes...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: